胃卡波西肉瘤中18F-FDG与68Ga-FAPI PET/CT的比较
本文报告一例转移性卡波西肉瘤患者的18F-FDG PET/CT与68Ga-FAPI-4 PET/CT结果。47岁男性因疑似胃癌接受18F-FDG PET/CT诊断和分期,检出转移性淋巴结和肝脏病灶的18F-FDG摄取增高;68Ga-FAPI-4 PET/CT因正在进行的临床试验而实施。68Ga-FAPI-4 PET/CT可能比18F-FDG更适合显示胃原发肿瘤浸润,而18F-FDG似乎更有助于确定卡波西肉瘤的病变范围和转移灶定位。
要点
- 47岁男性疑似胃癌行18F-FDG PET/CT,检出转移性淋巴结和肝脏病灶摄取增高。
- 因进行中的临床试验另行68Ga-FAPI-4 PET/CT。
- 68Ga-FAPI-4可能更适合显示胃原发肿瘤浸润,18F-FDG似乎更有助于确定病变范围和转移灶定位。
核心结论
- 68Ga-FAPI-4 PET/CT可能比18F-FDG更适合显示胃原发肿瘤浸润,而18F-FDG似乎更有助于确定卡波西肉瘤的病变范围和转移灶定位。
研究设计与样本
- 本文报告一例转移性卡波西肉瘤患者的18F-FDG PET/CT与68Ga-FAPI-4 PET/CT结果。
主要发现
- 47岁男性因疑似胃癌接受18F-FDG PET/CT诊断和分期,检出转移性淋巴结和肝脏病灶的18F-FDG摄取增高。
- 68Ga-FAPI-4 PET/CT因正在进行的临床试验而实施。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Herein, we present the results of 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT of a patient with metastatic Kaposi sarcoma. A 47-year-old man with suspected gastric cancer was referred to 18F-FDG PET/CT for diagnosis and staging. PET/CT detected increased 18F-FDG uptake in metastatic lymphadenopathies and liver lesions. 68Ga-FAPI-4 PET/CT was performed for ongoing clinical trial. Although 68Ga-FAPI-4 PET/CT may be a better alternative than 18F-FDG for the imaging of primary tumoral infiltrations in the stomach, 18F-FDG seems to be a more useful agent for the Kaposi sarcoma in determining the extent of the disease and the localization of metastatic lesions.
引用
- Tatar G, Beyhan E, Erol Fenercioğlu Ö, et al. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma. Clin Nucl Med. 2022. PMID: 35930714. doi:10.1097/RLU.0000000000004172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。